Pacer BioThreat ETF

VIRS tracks a market-cap weighted index of US companies whose products or services address biological threats to human health.

ARK 21Shares Blockchain and Digital Economy Innovation ETF

Amplify Transformational Data Sharing ETF

Vaneck Digital India ETF

Global X Data Center & Digital Infrastructure ETF

Procure Disaster Recovery ETF

First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund

Amplify Online Retail ETF

iShares MSCI India ETF

INQQ The India Internet & Ecommerce ETF

iShares MSCI China ETF

First Trust Indxx Aerospace & Defense ETF

Engine NO 1 Transform Climate ETF

Proshares Online Retail ETF

Invesco Aerospace & Defense ETF

Global X Defense Tech ETF

Pacer Data And Digital Revolution ETF

AXS Esoterica NEXTG Economy ETF

As we face the last quarter of 2024, interest rates are finally heading down, kicked off by a 50 basis point Fed cut, the election race is too close to call, and global geopolitical instability remains a risk factor.

Disruptive Theme of the Week: Top ETF Themes Through Q3 2024

MALVERN, Pa.--(BUSINESS WIRE)--Pacer Advisors, Inc. to Close and Liquidate the Pacer BioThreat Strategy ETF (VIRS) and the Pacer CSOP FTSE China A50 ETF (AFTY).

Pacer Advisors, Inc. to Close and Liquidate the Pacer BioThreat Strategy ETF (VIRS) and the Pacer CSOP FTSE China A50 ETF (AFTY)

First Trust S-Network Streaming and Gaming ETF

First Trust Dow Jones Internet Index Fund

MicroSectors FANG+ ETN

Invesco Next Gen Media and Gaming ETF

Netflix

Netflix (NFLX) topped both earnings and revenue estimates and delivered its strongest first-quarter customer additions since the pandemic. However, it issued disappointing second-quarter revenue guidance, which dragged the stock down.

Netflix ETFs to Buy on the Dip Post Solid Q1 Earnings

Netflix has risen about 26% over the past three months and has a reasonable chance to beat earnings estimates.

What Lies in Store for Netflix ETF in Q1 Earnings?

Fidelity Disruptive Communications ETF

Vanguard Telecommunication Services ETF

Netflix topped both earnings and revenue estimates. It posted its best quarter in terms of subscriber growth in years.

ETFs to Buy on Netflix's Blowout Q3 Earnings

Netflix shares have plunged about 20% over the past three months amid the broad stock market weakness.

What Lies in Store for Netflix ETF in Q3 Earnings?

Global X Education ETF

Global X FinTech ETF

Global X Video Games & Esports ETF 

A highly-mutated Covid-19 variant designated as BA.2.86, referred to as "Pirola," has surfaced and been detected in many countries.

Social-Distancing ETFs Worth a Look As "Pirola" Covid Variant Spreads

Invesco Dynamic Media ETF

ProShares Nasdaq-100 Dorsey Wright Momentum ETF

Netflix (NFLX) topped earnings estimates while lagging on revenues. It also provided a downbeat revenue guidance.

ETFs to Add Gains on Netflix Q2 Solid Subscriber Growth

Netflix topped the earnings estimate while lagging on revenues. It also provided downbeat guidance.

ETFs to Click on Netflix's Mixed Q1 Results

Netflix saw no earnings estimate revision over the past 30 days for the to-be-reported quarter. It's earnings surprise history is impressive.

What's in Store for Netflix ETFs in Q1?

Netflix (NFLX) cheered investors as it easily surpassed the subscriber growth numbers but missed earnings estimates.

ETFs to Click on Netflix's Blowout Q4 Subscriber Growth

Netflix has reasonable chances of an earnings beat and has positive earnings revisions, which are generally a precursor to an earnings beat ahead of its Q4 report.

Netflix Set to Beat Q4 Earnings: ETFs to Buy

Global X Telemedicine & Digital Health ETF

Amplify Treatments Testing & Advancements ETF

Direxion Work From Home ETF

COVID-themed stocks and ETFs were winners in 2020 and some parts of 2021 due to a spike in global coronavirus cases. We may see the same trend again as new COVID variants are 'pretty troublesome.

Here's Why COVID-Themed ETFs May Come Back Under the Radar

The Biothreat ETF hit a new 52-week high. Can it soar further?

Biothreat ETF (VIRS) Hits New 52-Week High

The remainder of 2021 is expected to continue reeling under the spurt in coronavirus cases. Thus, a COVID-themed ETF could be a wise choice.

Bet On COVID-Themed ETFs as New Cases Rise Globally

Play COVID-Themed ETFs as US Labor Day Sees Rise in New Cases

Global X Genomics & Biotechnology ETF

iShares U.S. Pharmaceuticals ETF

SPDR S&P Health Care Equipment ETF

The Biden administration recently offered a $65 billion plan that U.S. officials say is aimed at combating the biological threats after the COVID-19 pandemic goes away.

Healthcare ETFs to Gain on $65-Billion Pandemic Protection Plan

SPDR S&P Capital Markets ETF

Nuveen Short-Term REIT ETF

Invesco Water Resources ETF

Simplify Volt Cloud and Cybersecurity Disruption ETF

We have highlighted five ETFs from different sectors that hit new peaks in the recent trading session and have been the leaders in their respective sector so far this year.

5 Sector ETFs At All-Time Highs

iShares Nasdaq Biotechnology ETF

SPDR S&P Biotech ETF

ETFs that look at a subsector of biotech have significantly outperformed broader biotech funds this year.

COVID Biotech ETFs Rise At Fever Pace

The rest of 2021 is expected to continue bearing the brunt of the coronavirus outbreak. Thus, a COVID-themed ETF could be a smart pick.

Are COVID-Themed ETFs Back in Focus as Delta Variant Fears Rise?

Invesco S&P 500 Equal Weight Communication Services ETF

John Hancock Multifactor Media and Communications ETF

After disappointing first-quarter earnings results, with lesser subscriber growth, investors are keen to watch whether Netflix managed to win subscribers in the second quarter amid stiff competition.

ETFs to Watch Ahead of Netflix Q2 Earnings

VanEck Vectors Biotech ETF

Virtus LifeSci Biotech Products ETF

Principal Healthcare Innovators Index ETF

Loncar Cancer Immunotherapy ETF

Direxion Daily Healthcare Bull 3x Shares

First Trust NYSE Arca Biotechnology Index Fund

Fidelity MSCI Health Care ETF

First Trust Nasdaq Pharmaceuticals ETF 

First Trust Health Care AlphaDEX Fund

abrdn Healthcare Investors 

abrdn Life Sciences Investors 

Defiance Nasdaq Junior Biotechnology ETF

iShares U.S. Healthcare ETF

John Hancock Multifactor Healthcare ETF

Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bull 3X Shares

Global X Longevity Thematic ETF

Invesco Dynamic Biotechnology & Genome ETF

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Invesco Dynamic Pharmaceuticals ETF

VanEck Vectors Pharmaceutical ETF

ProShares UltraShort Health Care

ProShares Ultra Health Care

Invesco S&P 500 Equal Weight Health Care ETF

Vanguard Health Care ETF

Health Care Select Sector SPDR Fund

SPDR S&P Pharmaceuticals ETF

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively resilient throughout the pandemic, we expect a full recovery in the latter half of this year, as operations that were disrupted return to normal.

Biotech Innovations Remain At Forefront

The first half of 2021 is expected to continue bearing the brunt of the coronavirus outbreak considering the pandemic's renewed resurgence thanks to variants. Thus, a COVID-themed ETF could be a smart pick.

What's in Store for COVID-Themed ETFs as New Cases Rise?

AbbVie

LeMaitre Vascular

The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets.

Healthcare: A Wide Choice Of Large And Well-Established Companies

The first half of 2021 is expected to continue bearing the brunt of the coronavirus outbreak. Thus, a COVID-themed ETF could be a smart pick.

News for Pacer BioThreat ETF ETF (VIRS)